THE Spice Girls are in “advanced negotiations” for a jukebox movie – a coming-of-age story about a Spice superfan. Featuring the band’s greatest hits, it is being produced by SeeSaw Films …
The Spice movie comes 13 years after the band, famed for their “girl power” mantra, released West End musical, Viva Forever.
Backed by Simon Fuller, the guru who formed the multi Brit-winning group, the show, however, flopped and was pulled after just six months. This latest development follows claims the Spice Girls will re-form in some way for their 30th anniversary next year., Victoria Beckham is said to be keen to do something that doesn’t require live singing.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Millwall in advanced talks to sign Bournemouth star TraversFootball Insider has been told by sources that Millwall are in advanced talks to sign Bournemouth and Republic of Ireland star Mark Travers
Lire la suite »
Charlton in advanced talks to sign Fankaty Dabo after Coventry exitFootball Insider has learned that Charlton Athletic are in advanced talks to sign former Coventry City defender Fankaty Dabo on a free transfer.
Lire la suite »
Kiltie loving advanced Saints role as midfielder aims to nail down starting spotThe creative Buddies talent has impressed so far this season playing further up the pitch.
Lire la suite »
New targeted therapy zolbetuximab extends survival for patients with advanced gastric cancerAn international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy, extended survival for patients with advanced gastric or gastroesophageal junction cancer that overexpressed a specific biomarker.
Lire la suite »
Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical modelsResearchers at The University of Texas MD Anderson Cancer Center have uncovered a functional role for KRAS mutations in pancreatic cancer and rapidly translated these findings into a novel therapeutic approach combining a KRAS G12D inhibitor with immune checkpoint inhibitors for early- and late-stage KRAS G12D-mutant pancreatic cancer. The combination therapy led to durable tumor elimination and significantly improved survival outcomes in preclinical models, leading to the launch of a Phase I clinical trial.
Lire la suite »
Final overall study analysis continues to show benefit of sacituzumab govitecan in advanced HR+ breast cancerA novel antibody-drug conjugate continues to demonstrate superior benefit for patients with HR+, HER2- metastatic breast cancer when compared to standard chemotherapy, according to a new study in The Lancet.
Lire la suite »